Neuroscience trials require high-precision, sensitive endpoint measurements, yet sponsors often face challenges with ...
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced ...
The market opportunities lie in comprehensive training on cross-regional veterinary medicine development, emphasizing regulatory and commercial strategies for the EU and USA. The course fosters ...
The main market opportunities include leveraging the growing segment of combination products, emphasizing safety and efficacy in design through effective risk management, and navigating regulatory ...
From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening ...
Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results